Raju Khatri, Ph.D.
Affiliations: | 2013 | Toxicology | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Raju Khatri"Parents
Sign in to add mentor| Anil K. Jaiswal | grad student | 2013 | University of Maryland Medical School | |
| (Role of Nrf2 Signaling in Therapeutic Resistance and Cancer Metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Portney BA, Arad M, Gupta A, et al. (2020) ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype. Oncogene |
| Khatri R, Shah P, Guha R, et al. (2018) Retraction: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer. Molecular Cancer Therapeutics. 17: 2491 |
| Portney BA, Khatri R, Meltzer WA, et al. (2018) ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20. Biochemical and Biophysical Research Communications |
| Khatri R, Shah P, Guha R, et al. (2015) Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer. Molecular Cancer Therapeutics. 14: 1728-37 |
| Niture SK, Khatri R, Jaiswal AK. (2014) Regulation of Nrf2-an update. Free Radical Biology & Medicine. 66: 36-44 |
| Khatri R, Niture SK, Jaiswal AK. (2010) Abstract 4131: Activation of PKC-delta inhibits apoptosis leading to mitomycin C resistance Cancer Research. 70: 4131-4131 |